This site is intended for healthcare professionals
Disease page

Prostate Cancer

Containing dedicated Learning Zones, guidelines, trials, journals and news
Read time: 0 mins
Last updated: 4th Aug 2022

Prostate cancer most often develops from prostatic intraepithelial neoplasia (PIN) in the prostate gland and can be described as localised, locally advanced or advanced (metastatic). Symptoms may include genito-urinary symptoms such as poor urinary stream and erectile dysfunction, or bone pain in cases where the disease has spread to the bones.

‘ARE YOU TESTING? DNA repair alterations in prostate cancer care and cascade testing in family members’

A key EMUC19 event of great relevance to changing clinical practice for prostate cancer care was an EACCME accredited symposium - view the video presentations here.

Prostate cancer is considered a slow growing cancer and is driven by the androgen axis. Subsequently, treatment for hormone sensitive prostate cancer (HSPC) revolves around androgen deprivation therapy (ADT) alongside radiation therapy and chemotherapy.